Forward Look New Therapies for Metastatic Lung Cancer Several targeted drugs were approved in 2020 to treat the most common type of lung cancer. by Ashley P. Taylor When Cancer’s Spread Is Limited People with cancer that has spread to only a few locations—called oligometastatic cancer—may benefit from aggressive local treatment. by Kate Yandell Survivor Profile A Return to Carnival With a renewed sense of purpose, stage IV lung cancer survivor Oswald Peterson returns to his parents’ native Trinidad to celebrate the Caribbean festival. by Lindsey Konkel Immunotherapy Indications Withdrawn In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs? by Anna Goshua Forward Look Scanning Disparities Whether lung cancer patients receive PET scans depends on race, according to a study. by Ashley P. Taylor Forward Look Support Services Help Improve Patient Outcomes Study suggests far-reaching benefits of mental health treatment. by Sharon Tregaskis More Choices to Treat Lung Cancer Advances in precision medicine and immunotherapy have led to better treatments for many patients with advanced lung cancer. But having a wider selection of therapies to choose from can make treatments more complex. by Kendall K. Morgan Targeted Therapy for Early-Stage Lung Cancer? A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion. by Ashley P. Taylor Forward Look Cancer Death Rate Decline Makes Headlines Experts say it’s necessary to look behind the statistics. by Delia O’Hara Caregiving With Confidence The Power of Anger Accepting this emotion can be the first step in channeling it for a constructive purpose. by Karen J. Bannan next Cancer Talk Coverage of the AACR Annual Meeting 2021 This year’s AACR Annual Meeting features the latest advances in basic, translational and clinical cancer research. The more than 13,000 attendees at the virtual event represent more than 70 countries. by Kevin McLaughlin Searching the Blood for Signs of Altered Immunity The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors. by Kate Yandell Immunotherapy Indications Withdrawn In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs? by Anna Goshua Cancer Did Not Cancel Our Plans After her husband’s diagnosis with metastatic cancer, Miriam Díaz-Gilbert made it her goal to keep him moving. by Miriam Díaz-Gilbert More Posts